Rockville, Md. – (April 24, 2024) – Cellphire Therapeutics, a pioneering biotechnology company developing next-generation cellular therapies, announces its nomination for Emerging Life Science Company of the Year award by the Maryland Tech Council (MTC).
The nomination underscores Cellphire's commitment to innovation and its contributions to the life sciences industry. With a focus on developing next-generation allogeneic cellular therapeutic technologies, Cellphire has emerged as a leader in the field, driving advancements that have the potential to revolutionize product availability.
"We are honored to be recognized by the Maryland Tech Council as a nominee for Emerging Life Science Company of the Year," said Rob Woods, Vice President of Business Operations at Cellphire Therapeutics. "This nomination reflects the dedication of our team and the transformative potential of our technology. We remain committed to advancing our vision of saving lives by creating transformative, stabilized cellular therapies."
The winner of the Emerging Life Science Company of the Year award will be announced at the Maryland Tech Council's annual awards ceremony on May 23rd, 2024. The event will bring together industry leaders, innovators, and stakeholders to celebrate excellence and achievement in the Maryland life sciences community.
For inquiries, please contact:
Rob Woods
Vice President, Business Operations
RWoods@Cellphire.com